News of the WeekPatents

NIH Declines to March In on Pricing AIDS Drug

+ See all authors and affiliations

Science  13 Aug 2004:
Vol. 305, Issue 5686, pp. 926
DOI: 10.1126/science.305.5686.926b

You are currently viewing the summary.

View Full Text

Summary

The National Institutes of Health (NIH) has rejected a controversial plea to use its legal muscle to rein in the spiraling cost of a widely used AIDS drug.

Related Content